The FDA has finalized its guidance on identity and safety information for New Dietary Ingredient Notifications (NDINs). But what does this mean for the dietary supplement industry?

In Episode 149 of The Orange Pill Podcast, we break down the finalized guidance, exploring the FDA’s recommendations for establishing ingredient identity, presenting safety evidence, and supporting safety conclusions.

With KGK Science’s regulatory expertise extending to Dr. Corey Hilmas, our Chief Regulatory Officer, who was involved in drafting the FDA’s original 2011 draft NDI guidance, this is a regulatory development particularly close to our team.

Tune in as we unpack what the finalized guidance means for the industry.